Journal of Oncology / 2022 / Article / Tab 1 / Research Article
Integrative Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unveils the Characteristics of the Immune Microenvironment and Prognosis Signature in Prostate Cancer Table 1 Roles of the 25 genes used in the prognosis signature.
Gene Role References ABCA2 Drug resistance and malignant progression Zhu et al. [95 ]; pasello et al. [96 ] ABCB6 Progression Karatas et al. [97 ] ABCB9 Drug resistance Guazzelli et al. [98 ] ACAP3 Prosurvival role Sullivan et al. [99 ] ACIN1 Belongs to the canonical apoptosis signaling pathway Ali et al. [100 ] ACOX2 Tumour progression Bjørklund et al. [101 ] ACRBP Paclitaxel resistance Whitehurst et al. [102 ] ACYP1 Tumorigenesis and progression; poor prognosis Zhou et al. [103 ] ADAM11 Tumour suppressor Ribeiro et al. [104 ] ADAMTS2 The inhibition of proliferation and angiogenesis of endothelial cells Kirana et al. [105 ] ADAP1 Metastasis and invasion Oga et al. [106 ] ADAP2 a key accessory protein for relaying signals via natural killer cell receptors Campbell and colonna [107 ] ABCC5 Accelerating tumour growth and migration Ji et al. [108 ] ADCK2 The proliferation and survival of cancer cells; regulation of superoxide activity Vierthaler et al. [109 ]; schoolmeesters et al. [110 ] ADH5 Associated with disease-free survival and metabolic functions ADRA1D Related to benign prostatic hyperplasia Kim et al. [111 ] AGAP2 Facilitating the growth of the prostate Zhao et al. [112 ] AGAP3 Putative driver gene Shimizu et al. [113 ] AGRN Critical to the tumour-promoting function of long noncoding RNA NEAT1 Li et al. [114 ] AHRR Tumour suppressor Burris et al. [115 ] AIFM1 The induction of apoptosis in a caspase-independent manner Liu et al. [116 ] AK5 Apoptosis inhibition and autophagy promotion Zhang et al. [117 ] AKAP7 Progression by regulating miR-526b-5p and SERP1 Mekhail et al. [118 ] AKR1C3 Promoting epithelial-mesenchymal transition and metastasis by activating ERK signaling Wang et al. [119 ] ALDH1A2 Reduction in ALDH1A2 protein is an early event in human prostate cancer Kim et al. [120 ]